NEW YORK, NY / ACCESS Newswire / October 24, 2025 / If you suffered a loss on your V.F. Corporation (NYSE:VFC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/v-f-corporation-lawsuit-submission-form?prid=173847&wire=1&utm_campaign=5 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call […]

NEW YORK, NY / ACCESS Newswire / October 24, 2025 / If you suffered a loss on your RCI Hospitality Holdings, Inc. (NASDAQ:RICK) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/rci-hospitality-holdings-inc-lawsuit-submission-form?prid=173848&wire=1&utm_campaign=2 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com

Today,TwinThread, a global leader in Industrial AI, announced the “Preview” release of TwinThread Advisor, a Generative AI assistant embedded in the TwinThread Industrial AI Platform. Purpose-built for operations teams, Advisor helpsoperators, engineers, and digital teams ideate, innovate, problem-solve, and collaborate more effectively. By automating manual tasks and providing immediate data-driven insights, Advisor dramatically reduces time-to-action

NEW YORK, NY / ACCESS Newswire / October 24, 2025 / If you suffered a loss on your Cytokinetics, Incorporated (NASDAQ:CYTK) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/cytokinetics-incorporated-lawsuit-submission-form-2?prid=173852&wire=1&utm_campaign=17 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

(NASDAQ:ATYR), LOS ANGELES, Oct. 24, 2025 (GLOBE NEWSWIRE) — The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against aTyr Pharma, Inc. (“aTyr” or “the Company”) (NASDAQ: ATYR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by

NEW YORK, NY / ACCESS Newswire / October 24, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Tandem Diabetes Care, Inc. ("Tandem Diabetes Care, Inc.") (NASDAQ:TNDM) concerning possible violations of federal securities laws. Tandem disclosed on August 7, 2025, that a malfunction had been identified in some of its

ATYR Investors Have Opportunity to Lead aTyr Pharma, Inc. Securities Fraud Lawsuit with the Schall Law Firm GlobeNewswire October 24, 2025 LOS ANGELES, Oct. 24, 2025 (GLOBE NEWSWIRE) — The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against aTyr Pharma, Inc. (“aTyr” or “the Company”) (NASDAQ:

NEW YORK, NY / ACCESS Newswire / October 24, 2025 / If you suffered a loss on your Semler Scientific, Inc. (NASDAQ:SMLR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/semler-scientific-inc-lawsuit-submission-form?prid=173846&wire=1&utm_campaign=12 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

KuCoin, a leading global crypto platform built on trust, is set to make its mark at Blockchain Life Dubai 2025 on October 28-29 at the Festival Arena. With a spotlight on Web3 evolution, trading strategies, and emerging mining hubs like the UAE, KuCoin will demonstrate its commitment to trust, innovation, and accessibility-right in the heart

NEW YORK, NY / ACCESS Newswire / October 24, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Protalix BioTherapeutics, Inc. ("Protalix BioTherapeutics, Inc.") (NYSE:PLX) concerning possible violations of federal securities laws. On October 17, 2025, Protalix and Chiesi Global Rare Diseases, Protalix’s partner in "the development, production and commercialization